Artivion, Inc. (AORT)Healthcare | Medical Devices | Kennesaw, United States | NYSE
37.72 USD
+0.98
(2.667%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 37.82 +0.10 (0.278%) ⇧ (April 17, 2026, 6:18 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ★★★★☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:36 p.m. EDT
Artivion presents a compelling medium-to-long-term opportunity in a capital-light medical device segment, supported by recent FDA approvals and strong revenue growth, though the current valuation hides significant risk. The lack of put hedging suggests retail is chasing the momentum around the 40 strike, ignoring the poor free cash flow and erratic payout history. Long-term holds are warranted for the product pipeline, but short-term traders should reduce positioning as expected returns model a slight downside gap over the next month. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.103406 |
| AutoETS | 0.103409 |
| MSTL | 0.107714 |
| AutoTheta | 0.113309 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 50% |
| H-stat | 4.06 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.587 |
| Excess Kurtosis | -0.59 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Ex Dividend Date | 2015-12-08 |
| Last Dividend Date | 2015-12-08 |
| Debt to Equity Ratio | 57.674 |
| Revenue per Share | 9.735 |
| Market Cap | 1,829,268,864 |
| Trailing P/E | 179.62 |
| Forward P/E | 32.63 |
| Beta | 1.62 |
| Profit Margins | 2.21% |
| Previous Name | CryoLife, Inc. |
| Website | https://artivion.com |
As of April 18, 2026, 10:36 p.m. EDT: Options activity indicates a bullish lean with limited downside hedge. Call volume significantly outpaces put volume across expirations, with the majority of open interest concentrated in out-of-the-money calls for the May and July periods. Implied Volatility for the May 15th expiration is stable, while July calls show near-zero IV suggesting low expected moves further out. Notably, put activity is extremely thin (minimal volume and OI), indicating a lack of retail protection at current levels.
| Date | Dividend | Yield % |
|---|---|---|
| 2015-12-09 | 0.030 | 0.288462 |
| 2015-09-09 | 0.030 | 0.311441 |
| 2015-06-10 | 0.030 | 0.270162 |
| 2015-03-11 | 0.030 | 0.292930 |
| 2014-12-10 | 0.030 | 0.289563 |
| 2014-09-10 | 0.030 | 0.303703 |
| 2014-06-11 | 0.030 | 0.338765 |
| 2014-03-12 | 0.028 | 0.300228 |
| 2013-12-11 | 0.028 | 0.282961 |
| 2013-09-11 | 0.028 | 0.449071 |
| 2013-06-12 | 0.028 | 0.469367 |
| 2013-03-12 | 0.025 | 0.422340 |
| 2012-12-12 | 0.025 | 0.433272 |
| 2012-09-12 | 0.025 | 0.467789 |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.6742122 |
| Address1 | 1,655 Roberts Boulevard NW |
| All Time High | 48.25 |
| All Time Low | 1.4 |
| Ask | 39.42 |
| Ask Size | 500 |
| Audit Risk | 2 |
| Average Analyst Rating | 1.3 - Strong Buy |
| Average Daily Volume10 Day | 464,650 |
| Average Daily Volume3 Month | 441,591 |
| Average Volume | 441,591 |
| Average Volume10Days | 464,650 |
| Beta | 1.624 |
| Bid | 36.17 |
| Bid Size | 300 |
| Board Risk | 4 |
| Book Value | 9.369 |
| City | Kennesaw |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 2 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 37.72 |
| Current Ratio | 3.526 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 38.525 |
| Day Low | 37.13 |
| Debt To Equity | 57.674 |
| Display Name | Artivion |
| Earnings Call Timestamp End | 1,770,931,800 |
| Earnings Call Timestamp Start | 1,770,931,800 |
| Earnings Timestamp | 1,770,930,000 |
| Earnings Timestamp End | 1,777,924,800 |
| Earnings Timestamp Start | 1,777,924,800 |
| Ebitda | 53,797,000 |
| Ebitda Margins | 0.12189999 |
| Enterprise To Ebitda | 37.173 |
| Enterprise To Revenue | 4.531 |
| Enterprise Value | 1,999,786,624 |
| Eps Current Year | 0.812 |
| Eps Forward | 1.156 |
| Eps Trailing Twelve Months | 0.21 |
| Esg Populated | 0 |
| Ex Dividend Date | 1,449,619,200 |
| Exchange | NYQ |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 37.0724 |
| Fifty Day Average Change | 0.6476021 |
| Fifty Day Average Change Percent | 0.017468577 |
| Fifty Two Week Change Percent | 67.42122 |
| Fifty Two Week High | 48.25 |
| Fifty Two Week High Change | -10.529999 |
| Fifty Two Week High Change Percent | -0.21823832 |
| Fifty Two Week Low | 22.22 |
| Fifty Two Week Low Change | 15.500002 |
| Fifty Two Week Low Change Percent | 0.69756985 |
| Fifty Two Week Range | 22.22 - 48.25 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 729,527,400,000 |
| Float Shares | 45,398,244 |
| Forward Eps | 1.156 |
| Forward P E | 32.629757 |
| Free Cashflow | -20,097,624 |
| Full Exchange Name | NYSE |
| Full Time Employees | 1,800 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.64402 |
| Gross Profits | 284,227,008 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.04522 |
| Held Percent Institutions | 0.91141 |
| Implied Shares Outstanding | 48,495,993 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Ir Website | http://phx.corporate-ir.net/phoenix.zhtml?c=80253&p=irol-IRHome |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Dividend Date | 1,449,619,200 |
| Last Dividend Value | 0.03 |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 977,961,600 |
| Last Split Factor | 3:2 |
| Long Business Summary | Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides NEXUS DUO, an aortic arch system; NEXUS TRE, a custom-made three branch graft; E-vita thoracic 3G, a stent graft system; E-xtra Design Engineering, a range of stent graft systems for the treatment of aortic vascular diseases, such as TAAA and Artivex; E-nside, a multibranch stent graft system; E-tegra, an AAA stent graft system; E-ventus BX and Tuva BX balloon-expandable peripheral stent grafts; and E-liac, a stent graft used to treat aneurysmal iliac arteries. In addition, the company offers synthetic vascular grafts that are used in open aortic and peripheral vascular surgical procedures; BioGlue, a surgical sealant; CryoValve SG pulmonary heart valve; CryoPatch SG pulmonary cardiac patch; SynerGraft, a decellularization technology; vascular preservation services; and PhotoFix, a bovine pericardial patch fixated. It markets its products and preservation services primarily to physicians through a direct sales team to hospitals and other healthcare facilities. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia. |
| Long Name | Artivion, Inc. |
| Market | us_market |
| Market Cap | 1,829,268,864 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_27212 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-19 |
| Net Income To Common | 9,757,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 1,829,268,855 |
| Number Of Analyst Opinions | 7 |
| Open | 37.18 |
| Operating Cashflow | 39,880,000 |
| Operating Margins | 0.0809 |
| Overall Risk | 3 |
| Payout Ratio | 0.0 |
| Peg Ratio | 643.75 |
| Phone | 770 419 3355 |
| Post Market Change | 0.104969025 |
| Post Market Change Percent | 0.2782848 |
| Post Market Price | 37.82497 |
| Post Market Time | 1,776,464,281 |
| Prev Name | CryoLife, Inc. |
| Previous Close | 36.74 |
| Price Eps Current Year | 46.453205 |
| Price Hint | 2 |
| Price To Book | 4.0260434 |
| Price To Sales Trailing12 Months | 4.1449003 |
| Profit Margins | 0.022130001 |
| Quick Ratio | 1.66 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.28571 |
| Region | US |
| Regular Market Change | 0.98 |
| Regular Market Change Percent | 2.66739 |
| Regular Market Day High | 38.525 |
| Regular Market Day Low | 37.13 |
| Regular Market Day Range | 37.13 - 38.525 |
| Regular Market Open | 37.18 |
| Regular Market Previous Close | 36.74 |
| Regular Market Price | 37.72 |
| Regular Market Time | 1,776,456,002 |
| Regular Market Volume | 196,666 |
| Return On Assets | 0.0234 |
| Return On Equity | 0.026970001 |
| Revenue Growth | 0.192 |
| Revenue Per Share | 9.735 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 4 |
| Shares Outstanding | 48,495,993 |
| Shares Percent Shares Out | 0.0344 |
| Shares Short | 1,667,100 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,575,745 |
| Short Name | Artivion, Inc. |
| Short Percent Of Float | 0.041300002 |
| Short Ratio | 4.28 |
| Source Interval | 15 |
| State | GA |
| Symbol | AORT |
| Target High Price | 58.0 |
| Target Low Price | 42.0 |
| Target Mean Price | 51.57143 |
| Target Median Price | 53.0 |
| Total Cash | 64,908,000 |
| Total Cash Per Share | 1.356 |
| Total Debt | 258,514,000 |
| Total Revenue | 441,329,984 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.21 |
| Trailing P E | 179.61906 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 40.368 |
| Two Hundred Day Average Change | -2.6479988 |
| Two Hundred Day Average Change Percent | -0.06559648 |
| Type Disp | Equity |
| Volume | 196,666 |
| Website | https://artivion.com |
| Zip | 30,144 |